Stockreport

Why Esperion Therapeutics' Shares Fell Despite Its Good News [The Motley Fool]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Esperion Therapeutics shares fell after it reported clinical trial data for its promising cholesterol drug. On Wednesday,  Esperion Therapeutics ( NASDAQ:ESP [Read more]